Andros, a provider of network management solutions, has announced that Jeff Fritz will replace Mike Simmons as its new CEO. Simmons founded Andros in 2013 and helped establish it as an industry leader. The company's focus is on providing technology to help payors ensure access for their members with strong and diverse provider ecosystems. Fritz brings over 20 years of experience in healthcare & ..
Enochian Biosciences' Cancer Platform on Track for Human Trials by 2024 Enochian Biosciences has announced that its innovative Cancer Platform is expected to undergo clinical trials in humans during the first half of 2024. The US Food and Drug Administration (FDA) recently confirmed this after reviewing Enochian's Pre-Investigational New Drug Application submission. The company’s technology uses..
Medical Technology Associates (MTA) has announced its acquisition of Premier Medical, a Tennessee-based medical gas services and equipment company. The acquisition expands MTA's national presence into Arkansas and Tennessee while strengthening its market-leading position in Florida. Founded in 2000 by Christian Rife, Premier is known for its high-quality employees and marquis customer base. Brin..
Femasys Inc. has received approval from Health Canada for its FemCath intrauterine catheter, which is the first device to allow selective evaluation of fallopian tubes with contrast in the country. The product works together with Femasys' FemVue ultrasound-based diagnostic test as part of an infertility assessment before any therapeutic options can be considered, such as artificial insemination ..
Indica Labs has launched a new service that offers the deployment and ongoing support of its HALO digital pathology software in a fully managed cloud-hosted environment powered by Amazon Web Services (AWS). This includes their entire suite of HALO software, including the HALO Image Analysis platform. The offering is led by Indica Labs' new Professional Services group, which are AWS Certified Sol..
Roche Diagnostics Corporation has gained approval from Health Canada for its Cerebrospinal Fluid (CSF) assays to measure three biomarkers in adults aged 55 and over, allowing physicians to diagnose Alzheimer's disease. The Elecsys® beta-Amyloid, Phospho-Tau(181P), and Total-Tau CSF tests can be carried out on automated immunoassay analyzers available across the country. These biomarkers help tra..
Medical technology company Avanos Medical, Inc. has sold its Respiratory Health business to SunMed Group Holdings, LLC in a definitive agreement. The deal includes substantially all of the assets primarily used in the RH business, including fixed assets and inventory, among others. SunMed is a leading North American manufacturer and distributor of consumable medical devices for anesthesia and re..
French AI company Iktos and Japanese firm Curreio have announced a collaboration agreement in the field of new drug discovery, combining generative design technology with cryo-electron microscopy platform to speed up and reduce costs associated with preclinical drug candidate creation for an undisclosed target. Under the agreement, Iktos’ Makya generative AI technology will be used alongside str..
CBRE's U.S. Life Sciences Research Talent 2023 report has identified the top nine emerging markets for researchers in the country, with Columbus, Cincinnati, and Indianapolis taking the top three spots due to their NIH funding of $306m, $262m and $240m respectively. Other data points such as graduation rates and overall growth were also considered in making a comprehensive analysis of each city'..
California-based start-up Bitterroot Bio has launched with a focus on developing immunotherapies for cardiovascular diseases, following a successful $145m series A funding round. The company was founded by Irving Weissman and Nicholas Leeper from the Stanford University School of Medicine in 2021 and is focused on cardio-immunology. Its lead programme, BRB-002 targets CD47/SIRPα pathways underly..
